Regenerating the Cardiovascular System Through Cell Reprogramming; Current Approaches and a Look Into the Future

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Cardiovascular Research

Background:

• Cardiovascular disease (CVD) remains a leading global cause of mortality.
• Induced pluripotent stem cells (iPS cells) enable patient-specific in vitro disease models.
• Cell reprogramming has led to in vitro and in vivo therapeutic strategies.

Purpose of the Study:

• To review current research on cell reprogramming for cardiovascular regeneration.
• To highlight the potential of ex vivo models for overcoming therapeutic challenges.

Main Methods:

• Utilizing iPS cell technology for disease-specific in vitro models.
• Exploring in situ transdifferentiation for in vivo cell therapies.
• Proposing the development of multicellular 3D ex vivo models.

Main Results:

• Patient-specific cell lines facilitate in vitro pathophysiology studies and drug development.
• In vivo models show promise for cardiomyocyte and endothelial cell generation.
• Current cell therapy methods face efficiency and safety hurdles for clinical trials.

Conclusions:

• Ex vivo models using patient-specific cells are crucial for future cardiovascular regeneration.
• Multicellular 3D ex vivo models can significantly advance therapeutic strategies.
• Further research is needed to improve the efficiency and safety of cell-based therapies for CVD.